Scientific Online Resource System

Scripta Scientifica Medica

Experimental models of metabolic syndrome in rats

Silvia Gancheva, Maria Zhelyazkova-Savova, Bistra Galunska, Trifon Chervenkov

Abstract

Metabolic syndrome (MS) is a disorder comprising central obesity, dyslipidemia, raised blood pressure, insulin resistance.The aim of the present study was to develop a cheap, easy and reproducible rat model of MS. 36 male Wistar rats were divided in 3 groups: a control group (C) receiving regular rat chow diet, a high-fat (HF) group receiving lard enriched rat chow and a high-fat high-fructose (HFHF) group receiving lard and fructose enriched rat chow. HF and HFHF groups had also 10% fructose in their drinking water. The duration of the study was 8 weeks. Body weights were measured weekly. At the end of the study insulin tolerance test (ITT) was performed. Liver and fat weight index were measured after sacrifice. Lipid biochemical parameters and insulin concentration in serum were determined. Liver triglycerides (TG) were measured. The oxidative stress in serum was assessed by thiobarbituric reactive substances (TBARS). At the end of the study the animals did not differ in their body weights across the groups, but the fat index in both HF and HFHF groups was higher. Plasma TG and cholesterol were raised in both groups and the ratio cholesterol/HDL-cholesterol was higher. Liver TG were elevated in HFHF rats. ITT revealed reduced insulin sensitivity in both experimental groups although serum insulin was elevated only in HFHF group. TBARS were increased in both HF and HFHF groups. Both models displayed most of the features of MS; the HFHF probably better reflects the ‘cafeteria` diet and its unhealthy consequences.


Keywords

metabolic syndrome; rat model; high fat diet; high fat high fructose diet

Full Text


References

The IDF consensus worldwide definition of the metabolic syndrome 2006

The DECODE Insulin Study Group Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia. 2004;47:1245–56.

Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD,et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087-94.

Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002;106:3143–3421.

García ME, Marra CA, Rebolledo OR. Glycoxidative stress-induced damage on lipid profile in a fructose-enriched diet model of insulin resistance in rats. Archives of Physiology and Biochemistry. 2010;116(1):42-49.

Maiztegui B, Borelli MI, Raschia MA, Del Zotto H, Gagliardino JJ. Islet adaptive changes to fructose-induced insulin resistance: b-cell mass, glucokinase, glucose metabolism, and insulin secretion. Journal of Endocrinology. 2009;200:139–149.

Castro MC, Massa ML, Del Zotto H, Gagliardino JJ, Francini F. Rat liver uncoupling protein 2: Changes induced by a fructose-rich diet . Life Sciences 2011; 89: 609–614

Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. Journal of Molecular Endocrinology. 2006;36:485–501.

Buettner R, Schölmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring). 2007;15:798–808.

Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V, et al. High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011;57(1):51-64.

Couturier K, Batandier C, Awada M, Hininger-Favier I, Canini F, Anderson RA, et al. Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome. Archives of Biochemistry and Biophysics. 2010;50:158–161.

De Castro UG, dos Santos RA, Silva ME, de Lima WG, Campagnole-Santos MJ, Alzamora AC. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. Lipids in Health and Disease. 2013;12:136.

Panchal SK, Poudyal H, Arumugam TV, Brown L. Rutin Attenuates Metabolic Changes, Nonalcoholic Steatohepatitis, and Cardiovascular Remodeling in High-Carbohydrate, High-Fat Diet-Fed Rats. The Journal of Nutrition. 2011;141:1062–1069.

Fluttert M, Dalm S, Oitzl MS. A refined method for sequential blood sampling by tail incision in rats Laboratory. Animals. 2000;34:372-378.

Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, et al. Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men. Archives of Internal Medicine. 2001;161(22):2685-2692.

Dobiásová M, Frohlichb J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FERHDL). Clinical Biochemistry. 2001;34(7):583–588.

Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry. 1979;95(2):351–358.

Nagai Y, Yonemitsu S, Erion DM, Iwasaki T, Stark R, Weismann D, et al. The Role of Peroxisome Proliferator-activated Receptor Gamma Coactivator 1 beta (PGC-1β) in the Pathogenesis of Fructose-Induced Insulin Resistance. Cell Metab. 2009; 9(3): 252–264.

Jing A, Ning W, Mei Y, Zhi-Min D, Yong-Chun Z, Bao-Feng Y. Development of Wistar rat model of insulin resistance. World J Gastroenterol. 2005;11(24):3675-3679.

Mamikutty N, Thent ZC, Sapri SR, Sahruddin NN, Yusof MRM, Suhaimi FH. The Establishment of Metabolic Syndrome Model by Induction of Fructose Drinking Water in Male Wistar Rats. BioMed Research International. 2014; ID 263897; doi:10.1155/2014/263897

Panchal S, Brown L. Rodent Models for Metabolic Syndrome Research. Journal of Biomedicine and Biotechnology. 2011;ID 351982; doi:10.1155/2011/351982

Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab. 2010; 299(5): 685-694.

Alam A, Kauter K, Brown L. Naringin Improves Diet-Induced Cardiovascular Dysfunction and Obesity in High Carbohydrate, High Fat Diet-Fed Rats. Nutrients. 2013;5:637-650.

Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97(12):2859–2865.

Funaki M. Saturated fatty acids and insulin resistance. J. Med. Invest. 2009;56:88-92.

Cordain L, Eades MR, Eades MD. Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol. 2003;136(1):95-112.

Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. Canadian Medical Association Journal. 2005;172(7):899–905.

Basaranoglu М, Basaranoglu G, Sabuncu T, Sentürk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol. 2013; 19(8): 1166-1172.

Ando K, Fujita T. Metabolic syndrome and oxidative stress. Free Radical Biology & Medicine. 2009;47:213–218.

Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sciences 2009;84:705–712.

Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: The oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases 2010;20(1):72–77.

Eriksson JW. Metabolic stress in insulin’s target cells leads to ROS accumulation – A hypothetical common pathway causing insulin resistance. EFBS Letters 2007;581(19):3734–3742.

Girard A, Madani S, Boukortt F, Cherkaoui-Malki M, Belleville J, Prost J. Fructose-enriched diet modifies antioxidant status and lipid metabolism in spontaneously hypertensive rats. Nutrition. 2006;22:758–766.




DOI: http://dx.doi.org/10.14748/ssm.v47i2.1145
Array
About The Authors

Silvia Gancheva
Medical university of Varna
Bulgaria

Department of preclinical and clinical pharmacology

Maria Zhelyazkova-Savova
Medical university of Varna
Bulgaria

Department of preclinical and clinical pharmacology

Bistra Galunska
Medical university of Varna
Bulgaria

Department of Pharmaceutical Technologies

Trifon Chervenkov
Medical university of Varna
Bulgaria

Department of pediatrics and medical genetics

Font Size


|